VEGF and its receptors (flt-1 and KDR/flk-1) as prognostic indicators in endometrial carcinoma

Vascular endothelial growth factor ( VEGF) is associated with increased angiogenesis and aggressive tumour growth. We investigated the expression and clinical significance of VEGF and its receptors, flt-1 and KDR/flk-1, in patients with uterine endometrial carcinoma. The series consisted of 115 endometrioid endometrial adenocarcinoma patients with FIGO stage I - IV. Additionally, samples from 3 patients with adenoacanthoma and 12 patients with poor prognostic variants of endometrial carcinoma were examined. Immunohistochemical assessment was classified as negative or positive based on staining intensity. The median follow-up time of patients with endometrioid endometrial adenocarcinoma was 87 months. In endometrioid endometrial carcinomas, the positive immunostaining rate was 39% for VEGF, 65% for flt-1 and 68% for KDR/flk-1. There was a significant correlation between VEGF and both its receptors. Furthermore, this receptor expression was correlated between the two types of receptors. VEGF-,flt-1- and KDR/ flk-1-positive immunostainings were not related to poor prognosis. We conclude that VEGF, flt-1 and KDR/ flk-1 expressions are not useful prognostic markers for overall survival in patients with endometrioid endometrial carcinoma. Copyright (C) 2005 S. Karger AG, Basel.